Reuters Photojournalism
Our day's top images, in-depth photo essays and offbeat slices of life. See the best of Reuters photography. See more | Photo caption
Ethiopia's salt trails
For centuries merchants have traveled to Ethiopia to collect salt from the surface of the vast desert basin. Slideshow
Sponsored Links
FDA sees side effects with ThromboGenics' eye drug
BRUSSELS |
BRUSSELS (Reuters) - ThromboGenics' main drug, the eye treatment ocriplasmin, may have a high rate of adverse side effects, the U.S. Food and Drug Administration said that in a preliminary report made available on Tuesday.
"There are several adverse events which occur at a much higher rate in ocriplasmin treated patients which raise concerns about the drug's potential effect on the retina," the FDA said in the report issued two days before a panel is due to decide on whether to approve the drug.
The FDA report added that these side effects may cause no long-term harm, but it that it did not have enough data to know for sure.
(Reporting By Ben Deighton)
- Tweet this
- Link this
- Share this
- Digg this
- Reprints
Follow Reuters